Connect with us
A Carlos III Health Institute team showed CRISPR-based gene therapy effectively targets Ewing sarcoma in preclinical models. Using a tumor-specific promoter, the treatment avoids harming healthy...
CNIC researchers have developed a promising gene therapy for ARVC5, a lethal genetic heart disease. By delivering a healthy TMEM43 gene via AAV vectors, they improved...
Biotech stocks are currently out of favor, but analysts believe sentiment may have bottomed out, creating a buying opportunity—especially for undervalued small and mid-cap firms. Concerns...
Northwestern University researchers have created the world’s smallest, dissolvable pacemaker for critically ill newborns. Injected via syringe and activated by a chest patch using infrared light,...
The CNAG closed 2024 as a leader in precision medicine, doubling sequencing capacity and advancing diagnostics for complex diseases. It contributed to major projects, including rare...
AstraZeneca and 13 scientific societies signed a document promoting a multidisciplinary approach to cardio-renal-metabolic diseases. The agreement emphasizes early diagnosis, care coordination, research, awareness, screening, equitable...
Sylentis, part of PharmaMar Group, secured a €21.1M NextGenerationEU grant for its Syoligo project—Spain’s first RNA drug production plant. Located in Getafe, Madrid, it will focus...
Ulisse Biomed, a biotech company in Trieste’s Area Science Park, collaborates with Johns Hopkins University and the Gates Foundation on a malaria project in Cameroon. Its...
Novo Nordisk is licensing United Laboratories’ experimental triple agonist obesity drug, UBT251, for $200M upfront, with potential payments up to $1.8B. This move strengthens its pipeline...
Sofinnova Partners’ Biovelocità II fund raised €165 million, surpassing expectations with support from Amgen, Bristol Myers Squibb, and Pfizer. Expanding across Europe, it backs biotech startups...
 |
|
 |  |
 |
|